These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28992999)

  • 21. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
    Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E
    Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.
    Lee MS; Park KW; Kang SH; Sheiban I; Mahmud E; Thani KB; Cheng R; Cho JH; Jin DK; Gwon HC; Chae IH; Aragon J; Gillis K; Stone GW; Kim HS
    J Invasive Cardiol; 2012 Jul; 24(7):316-9. PubMed ID: 22781468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of interventional strategy for unprotected left main coronary artery percutaneous coronary intervention on long-term survival.
    Lehmann R; Ehrlich JR; De Rosa S; Spyridopoulos I; Laskowski R; Kremer J; Herrmann E; Zeiher AM; Schächinger V; Fichtlscherer S
    Can J Cardiol; 2012; 28(5):553-60. PubMed ID: 22554579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
    Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
    Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Biolè C; Huczek Z; Nuñez-Gil I; Boccuzzi G; Autelli M; Montefusco A; Trabattoni D; Ryan N; Venuti G; Imori Y; Takano H; Matsuda J; Shimizu W; Muscoli S; Montabone A; Wojakowski W; Rognoni A; Helft G; Gallo D; Parma R; De Luca L; Figini F; Mitomo S; Pennone M; Mattesini A; Templin C; Quadri G; Wańha W; Cerrato E; Smolka G; Protasiewicz M; Kuliczkowski W; Rolfo C; Cortese B; Capodanno D; Chieffo A; Morbiducci U; Iannaccone M; Gili S; di Mario C; D'Amico M; Romeo F; Lüscher TF; Sheiban I; Escaned J; Varbella F; D'Ascenzo F
    Int J Cardiol; 2019 Sep; 290():64-69. PubMed ID: 30971372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Planned angiographic control versus clinical follow-up for patients with unprotected left main stem stenosis treated with second generation drug-eluting stents: A propensity score with matching analysis from the FAILS (failure in left main with second generation stents-Cardiogroup III Study).
    D'Ascenzo F; Iannaccone M; Pavani M; Kawamoto H; Escaned J; Varbella F; Boccuzzi G; Hiddick-Smith D; Colombo A; Gaita F
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):E271-E277. PubMed ID: 29130573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Richardt G; Valgimigli M; Schulz S; Singh A; Abdel-Wahab M; Tiroch K; Pache J; Hausleiter J; Byrne RA; Ott I; Ibrahim T; Fusaro M; Seyfarth M; Laugwitz KL; Massberg S; Kastrati A;
    J Am Coll Cardiol; 2013 Dec; 62(22):2075-82. PubMed ID: 23973699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Coronary Intervention for Left Main Coronary Artery Bifurcation Lesions: Two-stent versus one-stent Strategy for Comparison of 6-month MACE.
    Nasir M; Shafique HM; Hussain S; Tuyyab F; Aziz S; Khadim R
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):894-899. PubMed ID: 33036670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
    Kherada NI; Sartori S; Tomey MI; Mennuni MG; Meelu OA; Roy S; Mohanty BD; Baber U; Pyo R; Kovacic JC; Sweeny J; Moreno P; Krishnan P; Dangas GD; Mehran R; Sharma SK; Kini AS
    Int J Cardiol; 2014 Jun; 174(1):13-7. PubMed ID: 24731975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous coronary intervention of unprotected left main disease: five-year outcome of a single-center registry.
    Dores H; Raposo L; Almeida MS; Brito J; Santos PG; Sousa PJ; Gabriel HM; Gonçalves PA; Teles RC; Machado FP; Mendes M
    Rev Port Cardiol; 2013 Dec; 32(12):997-1004. PubMed ID: 24287023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in left main coronary artery stenting: Different characteristics but similar outcomes for women compared with men.
    Shin ES; Lee CW; Ahn JM; Lee PH; Chang M; Kim MJ; Yoon SH; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Int J Cardiol; 2018 Feb; 253():50-54. PubMed ID: 29306470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of drug-eluting stents versus bare-metal stents for the treatment of left main coronary artery disease.
    Wang XZ; Xu K; Li Y; Jing QM; Liu HW; Zhao X; Wang G; Wang B; Ma YY; Chen SL; Han YL
    Chin Med J (Engl); 2015 Mar; 128(6):721-6. PubMed ID: 25758262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stents.
    Koh YS; Kim PJ; Chang K; Park HJ; Jeong MH; Kim HS; Jang Y; Gwon HC; Park SJ; Seung KB
    J Interv Cardiol; 2013 Jun; 26(3):245-53. PubMed ID: 23480867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW;
    J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
    Buchanan GL; Chieffo A; Meliga E; Mehran R; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Allgar V; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    Am J Cardiol; 2014 Apr; 113(8):1348-55. PubMed ID: 24581924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy.
    Lee MS; Shlofmitz E; Kaplan B; Shlofmitz R
    J Invasive Cardiol; 2016 Apr; 28(4):147-50. PubMed ID: 27031936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results after PCI of unprotected distal left main coronary artery stenosis: the Bifurcations Bad Krozingen (BBK)-Left Main Registry.
    Ferenc M; Banholzer N; Hochholzer W; Mashayekhi K; Comberg T; Rothe J; Valina CM; Toma A; Löffelhardt N; Gick M; Neumann FJ; Nührenberg TG
    Clin Res Cardiol; 2019 Feb; 108(2):175-184. PubMed ID: 30051181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of left circumflex coronary artery ostium stenosis on outcomes for patients after percutaneous coronary intervention for unprotected left main disease.
    Skorupski WJ; Kałużna-Oleksy M; Mitkowski P; Araszkiewicz A; Skorupski W; Grajek S; Pyda M; Lesiak M; Grygier M
    Kardiol Pol; 2023; 81(9):903-908. PubMed ID: 37489824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.